Followers | 813 |
Posts | 71331 |
Boards Moderated | 2 |
Alias Born | 01/30/2003 |
Monday, February 01, 2016 6:18:56 PM
$BCRX Grabbed at 6.90 End Of Day, $BCRX recent news/filings
## source: finance.yahoo.com
Thu, 28 Jan 2016 18:25:21 GMT ~ Billionaire Ubben Cuts Stake in Adobe (ADBE), Carlson Buys More Archrock (AROC), and 2 Other Moves
read full: http://www.insidermonkey.com/blog/billionaire-ubben-cuts-stake-in-adobe-adbe-carlson-buys-more-archrock-aroc-and-2-other-moves-412522/
*********************************************************
Wed, 27 Jan 2016 17:20:00 GMT ~ 5 Stocks Insiders Love Right Now
read full: http://www.thestreet.com/story/13437924/1/5-stocks-insiders-love-right-now.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Sat, 23 Jan 2016 15:10:02 GMT ~ Warren Buffett Continues Massive Energy Insider Buying: Phillips 66, Summit Midstream, Lands’ End and More
read full: http://247wallst.com/investing/2016/01/23/warren-buffett-continues-massive-energy-insider-buying-phillips-66-summit-midstream-lands-end-and-more/
*********************************************************
Fri, 22 Jan 2016 16:10:17 GMT ~ These 4 Stocks Were Just Bought by Baker Bros. Advisors, Clint Carlson, More
read full: http://www.insidermonkey.com/blog/these-4-stocks-were-just-bought-by-baker-bros-advisors-clint-carlson-more-408751/
*********************************************************
Tue, 12 Jan 2016 13:35:06 GMT ~ Jefferies Has 5 Top Growth Stocks to Buy After Horrible 2016 Start
read full: http://247wallst.com/investing/2016/01/12/jefferies-has-5-top-growth-stocks-to-buy-after-horrible-2016-start/
*********************************************************
$BCRX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$BCRX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/BCRX/company-info
Ticker: $BCRX
OTC Market Place: Not Available
CIK code: 0000882796
Company name: BioCryst Pharmaceuticals, Inc.
Incorporated In: DE, USA
Business Description: OTC Markets | Official site of the OTCQX, OTCQB and OTC Pink Marketplaces featuring Free Stock & Bond Quotes, Trade Prices, Chart, Financials and Company News & Information for Investors, Companies and Traders - OTCMarkets.com (window.NREUM||(NREUM={})).loader_config={xpid:"UwMGWVdSGwQIU1RQAgQ="};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;oc;c++)a[c].apply(i,r);return i}function c(t,e){d[t]=f(t).concat(e)}function f(t){return d[t]||[]}function u(){return r(s)}var d={};return{on:c,emit:s,create:u,listeners:f,context:e,_events:d}}function o(){return new n}var i="nr@context",a=t("gos");e.exports=r()},{gos:"7eSDFh"}],ee:[function(t,e){e.exports=t("QJf3ax")},{}],3:[function(t){function e(t){try{i.console&&console.log(t)}catch(e){}}var n,r=t("ee"),o=t(1),i={};try{n=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(i.console=!0,-1!==n.indexOf("dev")&&(i.dev=!0),-1!==n.indexOf("nr_dev")&&(i.nrDev=!0))}catch(a){}i.nrDev&&r.on("internal-error",function(t){e(t.stack)}),i.dev&&r.on("fn-err",function(t,n,r){e(r.stack)}),i.dev&&(e("NR AGENT IN DEVELOPMENT MODE"),e("flags: "+o(i,function(t){return t}).join(", ")))},{1:25,ee:"QJf3ax"}],4:[function(t){function e(t,e,n,i,a){try{f?f-=1:r("err",[a||new UncaughtException(t,e,n)])}catch(c){try{r("ierr",[c,(new Date).getTime(),!0])}catch(u){}}return"function"==typeof s?s.apply(this,o(arguments)):!1}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function n(t){r("err",[t,(new Date).getTime()])}var r=t("handle"),o=t(6),i=t("ee"),a=t("loader"),s=window.onerror,c=!1,f=0;a.features.err=!0,t(5),window.onerror=e;try{throw new Error}catch(u){"stack"in u&&(t(1),t(2),"addEventListener"in window&&t(3),a.xhrWrappable&&t(4),c=!0)}i.on("fn-start",function(){c&&(f+=1)}),i.on("fn-err",function(t,e,r){c&&(this.thrown=!0,n(r))}),i.on("fn-end",function(){c&&!this.thrown&&f>0&&(f-=1)}),i.on("internal-error",function(t){r("ierr",[t,(new Date).getTime(),!0])})},{1:11,2:10,3:8,4:12,5:3,6:26,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],5:[function(t){if(window.addEventListener){var e=t("handle"),n=t("ee");t(1),window.addEventListener("click",function(){e("inc",["ck"])},!1),window.addEventListener("hashchange",function(){e("inc",["hc"])},!1),n.on("pushState-start",function(){e("inc",["ps"])})}},{1:9,ee:"QJf3ax",handle:"D5DuLP"}],6:[function(t){t("loader").features.ins=!0},{loader:"G9z0Bl"}],7:[function(t){function e(){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var n=t("ee"),r=t("handle"),o=t(1),i=t(2);t("loader").features.stn=!0,t(3);var a=Event;n.on("fn-start",function(t){var e=t[0];e instanceof a&&(this.bstStart=Date.now())}),n.on("fn-end",function(t,e){var n=t[0];n instanceof a&&r("bst",[n,e,this.bstStart,Date.now()])}),o.on("fn-start",function(t,e,n){this.bstStart=Date.now(),this.bstType=n}),o.on("fn-end",function(t,e){r("bstTimer",[e,this.bstStart,Date.now(),this.bstType])}),i.on("fn-start",function(){this.bstStart=Date.now()}),i.on("fn-end",function(t,e){r("bstTimer",[e,this.bstStart,Date.now(),"requestAnimationFrame"])}),n.on("pushState-start",function(){this.time=Date.now(),this.startPath=location.pathname+location.hash}),n.on("pushState-end",function(){r("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),"addEventListener"in window.performance&&(window.performance.clearResourceTimings?window.performance.addEventListener("resourcetimingbufferfull",function(){r("bstResource",[window.performance.getEntriesByType("resource")]),window.performance.clearResourceTimings()},!1):window.performance.addEventListener("webkitresourcetimingbufferfull",function(){r("bstResource",[window.performance.getEntriesByType("resource")]),window.performance.webkitClearResourceTimings()},!1)),document.addEventListener("scroll",e,!1),document.addEventListener("keypress",e,!1),document.addEventListener("click",e,!1)}},{1:11,2:10,3:9,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],8:[function(t,e){function n(t){for(var e=t;e&&!e.hasOwnProperty("addEventListener");)e=Object.getPrototypeOf(e);e&&r(e)}function r(t){a.inPlace(t,["addEventListener","removeEventListener"],"-",o)}function o(t){return t[1]}var i=t("ee").create(),a=t(1)(i),s=t("gos");e.exports=i,r(window),"getPrototypeOf"in Object?(n(document),n(XMLHttpRequest.prototype)):XMLHttpRequest.prototype.hasOwnProperty("addEventListener")&&r(XMLHttpRequest.prototype),i.on("addEventListener-start",function(t){if(t[1]){var e=t[1];if("function"==typeof e){var n=s(e,"nr@wrapped",function(){return a(e,"fn-",null,e.name||"anonymous")});this.wrapped=t[1]=n}else"function"==typeof e.handleEvent&&a.inPlace(e,["handleEvent"],"fn-")}}),i.on("removeEventListener-start",function(t){var e=this.wrapped;e&&(t[1]=e)})},{1:27,ee:"QJf3ax",gos:"7eSDFh"}],9:[function(t,e){var n=t("ee").create(),r=t(1)(n);e.exports=n,r.inPlace(window.history,["pushState","replaceState"],"-")},{1:27,ee:"QJf3ax"}],10:[function(t,e){var n=t("ee").create(),r=t(1)(n);e.exports=n,r.inPlace(window,["requestAnimationFrame","mozRequestAnimationFrame","webkitRequestAnimationFrame","msRequestAnimationFrame"],"raf-"),n.on("raf-start",function(t){t[0]=r(t[0],"fn-")})},{1:27,ee:"QJf3ax"}],11:[function(t,e){function n(t,e,n){t[0]=i(t[0],"fn-",null,n)}function r(t,e,n){this.method=n,this.timerDuration="number"==typeof t[1]?t[1]:0,t[0]=i(t[0],"fn-",this,n)}var o=t("ee").create(),i=t(1)(o);e.exports=o,i.inPlace(window,["setTimeout","setImmediate"],"setTimer-"),i.inPlace(window,["setInterval"],"setInterval-"),i.inPlace(window,["clearTimeout","clearImmediate"],"clearTimeout-"),o.on("setInterval-start",n),o.on("setTimer-start",r)},{1:27,ee:"QJf3ax"}],12:[function(t,e){function n(){f.inPlace(this,l,"fn-",o)}function r(t,e){f.inPlace(e,["onreadystatechange"],"fn-",o)}function o(t,e){return e}function i(t,e){for(var n in t)e[n]=t[n];return e}var a=t("ee").create(),s=t(1),c=t(2),f=c(a),u=c(s),d=window.XMLHttpRequest,l=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"];e.exports=a,window.XMLHttpRequest=function(t){var e=new d(t);try{a.emit("new-xhr",[e],e),e.hasOwnProperty("addEventListener")&&u.inPlace(e,["addEventListener","removeEventListener"],"-",o),e.addEventListener("readystatechange",n,!1)}catch(r){try{a.emit("internal-error",[r])}catch(i){}}return e},i(d,XMLHttpRequest),XMLHttpRequest.prototype=d.prototype,f.inPlace(XMLHttpRequest.prototype,["open","send"],"-xhr-",o),a.on("send-xhr-start",r),a.on("open-xhr-start",r)},{1:8,2:27,ee:"QJf3ax"}],13:[function(t){function e(t){var e=this.params,r=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;u>o;o++)t.removeEventListener(f[o],this.listener,!1);if(!e.aborted){if(r.duration=(new Date).getTime()-this.startTime,4===t.readyState){e.status=t.status;var i=this.lastSize||n(t);if(i&&(r.rxSize=i),this.sameOrigin){var s=t.getResponseHeader("X-NewRelic-App-Data");s&&(e.cat=s.split(", ").pop())}}else e.status=0;r.cbTime=this.cbTime,c.emit("xhr-done",[t],t),a("xhr",[e,r,this.startTime])}}}function n(t){var e=t.responseType,n="arraybuffer"===e||"blob"===e||"json"===e?t.response:t.responseText;return r(n)}function r(t){if("string"==typeof t&&t.length)return t.length;if("object"!=typeof t)return void 0;if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if("undefined"!=typeof FormData&&t instanceof FormData)return void 0;try{return JSON.stringify(t).length}catch(e){return void 0}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.sameOrigin=n.sameOrigin}var i=t("loader");if(i.xhrWrappable){var a=t("handle"),s=t(2),c=t("ee"),f=["load","error","abort","timeout"],u=f.length,d=t(1),l=t(3),p=window.XMLHttpRequest;i.features.xhr=!0,t(5),t(4),c.on("new-xhr",function(t){var n=this;n.totalCbs=0,n.called=0,n.cbTime=0,n.end=e,n.ended=!1,n.xhrGuids={},n.lastSize=0,l&&(l>34||10>l)||window.opera||t.addEventListener("progress",function(t){n.lastSize=t.loaded},!1)}),c.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),c.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid)}),c.on("send-xhr-start",function(t,e){var n=this.metrics,o=t[0],i=this;if(n&&o){var a=r(o);a&&(n.txSize=a)}this.startTime=(new Date).getTime(),this.listener=function(t){try{"abort"===t.type&&(i.params.aborted=!0),("load"!==t.type||i.called===i.totalCbs&&(i.onloadCalled||"function"!=typeof e.onload))&&i.end(e)}catch(n){try{c.emit("internal-error",[n])}catch(r){}}};for(var s=0;u>s;s++)e.addEventListener(f[s],this.listener,!1)}),c.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),c.on("xhr-load-added",function(t,e){var n=""+d(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),c.on("xhr-load-removed",function(t,e){var n=""+d(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),c.on("addEventListener-end",function(t,e){e instanceof p&&"load"===t[0]&&c.emit("xhr-load-added",[t[1],t[2]],e)}),c.on("removeEventListener-end",function(t,e){e instanceof p&&"load"===t[0]&&c.emit("xhr-load-removed",[t[1],t[2]],e)}),c.on("fn-start",function(t,e,n){e instanceof p&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=(new Date).getTime()))}),c.on("fn-end",function(t,e){this.xhrCbStart&&c.emit("xhr-cb-time",[(new Date).getTime()-this.xhrCbStart,this.onload,e],e)})}},{1:"XL7HBI",2:14,3:16,4:12,5:8,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],14:[function(t,e){e.exports=function(t){var e=document.createElement("a"),n=window.location,r={};e.href=t,r.port=e.port;var o=e.href.split("://");!r.port&&o[1]&&(r.port=o[1].split("/")[0].split("@").pop().split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]?"443":"80"),r.hostname=e.hostname||n.hostname,r.pathname=e.pathname,r.protocol=o[0],"/"!==r.pathname.charAt(0)&&(r.pathname="/"+r.pathname);var i=!e.protocol||":"===e.protocol||e.protocol===n.protocol,a=e.hostname===document.domain&&e.port===n.port;return r.sameOrigin=i&&(!e.hostname||a),r}},{}],15:[function(t,e){function n(t){return function(){r(t,[(new Date).getTime()].concat(i(arguments)))}}var r=t("handle"),o=t(1),i=t(2);"undefined"==typeof window.newrelic&&(newrelic=window.NREUM);var a=["setPageViewName","addPageAction","setCustomAttribute","finished","addToTrace","inlineHit","noticeError"];o(a,function(t,e){window.NREUM[e]=n("api-"+e)}),e.exports=window.NREUM},{1:25,2:26,handle:"D5DuLP"}],16:[function(t,e){var n=0,r=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);r&&(n=+r[1]),e.exports=n},{}],gos:[function(t,e){e.exports=t("7eSDFh")},{}],"7eSDFh":[function(t,e){function n(t,e,n){if(r.call(t,e))return t[e];var o=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:o,writable:!0,enumerable:!1}),o}catch(i){}return t[e]=o,o}var r=Object.prototype.hasOwnProperty;e.exports=n},{}],D5DuLP:[function(t,e){function n(t,e,n){return r.listeners(t).length?r.emit(t,e,n):void(r.q&&(r.q[t]||(r.q[t]=[]),r.q[t].push(e)))}var r=t("ee").create();e.exports=n,n.ee=r,r.q={}},{ee:"QJf3ax"}],handle:[function(t,e){e.exports=t("D5DuLP")},{}],XL7HBI:[function(t,e){function n(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:i(t,o,function(){return r++})}var r=1,o="nr@id",i=t("gos");e.exports=n},{gos:"7eSDFh"}],id:[function(t,e){e.exports=t("XL7HBI")},{}],G9z0Bl:[function(t,e){function n(){if(!h++){var t=p.info=NREUM.info,e=f.getElementsByTagName("script")[0];if(t&&t.licenseKey&&t.applicationID&&e){s(d,function(e,n){t[e]||(t[e]=n)});var n="https"===u.split(":")[0]||t.sslForHttp;p.proto=n?"https://":"http://",a("mark",["onload",i()]);var r=f.createElement("script");r.src=p.proto+t.agent,e.parentNode.insertBefore(r,e)}}}function r(){"complete"===f.readyState&&o()}function o(){a("mark",["domContent",i()])}function i(){return(new Date).getTime()}var a=t("handle"),s=t(1),c=window,f=c.document;t(2);var u=(""+location).split("?")[0],d={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-852.min.js"},l=window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&!/CriOS/.test(navigator.userAgent),p=e.exports={offset:i(),origin:u,features:{},xhrWrappable:l};f.addEventListener?(f.addEventListener("DOMContentLoaded",o,!1),c.addEventListener("load",n,!1)):(f.attachEvent("onreadystatechange",r),c.attachEvent("onload",n)),a("mark",["firstbyte",i()]);var h=0},{1:25,2:15,handle:"D5DuLP"}],loader:[function(t,e){e.exports=t("G9z0Bl")},{}],25:[function(t,e){function n(t,e){var n=[],o="",i=0;for(o in t)r.call(t,o)&&(n=e(o,t[o]),i+=1);return n}var r=Object.prototype.hasOwnProperty;e.exports=n},{}],26:[function(t,e){function n(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(0>o?0:o);++r
$BCRX share structure
## source: otcmarkets.com
Market Value: $511,157,991 a/o Jan 29, 2016
Shares Outstanding: 73,336,871 a/o Oct 31, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$BCRX extra dd links
Company name: BioCryst Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=BCRX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=BCRX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=BCRX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/news - http://finance.yahoo.com/q/h?s=BCRX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/BCRX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=BCRX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/BCRX
DTCC (dtcc.com): http://search2.dtcc.com/?q=BioCryst+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=BioCryst+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=BioCryst+Pharmaceuticals%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/BCRX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000882796&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=BCRX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=BCRX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=BCRX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=BCRX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=BCRX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=BCRX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=BCRX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/BCRX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=BCRX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/BCRX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=BCRX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/BCRX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/BCRX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/BCRX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=BCRX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=BCRX
$BCRX DD Notes ~ http://www.ddnotesmaker.com/BCRX
## source: finance.yahoo.com
Thu, 28 Jan 2016 18:25:21 GMT ~ Billionaire Ubben Cuts Stake in Adobe (ADBE), Carlson Buys More Archrock (AROC), and 2 Other Moves
read full: http://www.insidermonkey.com/blog/billionaire-ubben-cuts-stake-in-adobe-adbe-carlson-buys-more-archrock-aroc-and-2-other-moves-412522/
*********************************************************
Wed, 27 Jan 2016 17:20:00 GMT ~ 5 Stocks Insiders Love Right Now
read full: http://www.thestreet.com/story/13437924/1/5-stocks-insiders-love-right-now.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Sat, 23 Jan 2016 15:10:02 GMT ~ Warren Buffett Continues Massive Energy Insider Buying: Phillips 66, Summit Midstream, Lands’ End and More
read full: http://247wallst.com/investing/2016/01/23/warren-buffett-continues-massive-energy-insider-buying-phillips-66-summit-midstream-lands-end-and-more/
*********************************************************
Fri, 22 Jan 2016 16:10:17 GMT ~ These 4 Stocks Were Just Bought by Baker Bros. Advisors, Clint Carlson, More
read full: http://www.insidermonkey.com/blog/these-4-stocks-were-just-bought-by-baker-bros-advisors-clint-carlson-more-408751/
*********************************************************
Tue, 12 Jan 2016 13:35:06 GMT ~ Jefferies Has 5 Top Growth Stocks to Buy After Horrible 2016 Start
read full: http://247wallst.com/investing/2016/01/12/jefferies-has-5-top-growth-stocks-to-buy-after-horrible-2016-start/
*********************************************************
$BCRX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$BCRX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/BCRX/company-info
Ticker: $BCRX
OTC Market Place: Not Available
CIK code: 0000882796
Company name: BioCryst Pharmaceuticals, Inc.
Incorporated In: DE, USA
Business Description: OTC Markets | Official site of the OTCQX, OTCQB and OTC Pink Marketplaces featuring Free Stock & Bond Quotes, Trade Prices, Chart, Financials and Company News & Information for Investors, Companies and Traders - OTCMarkets.com (window.NREUM||(NREUM={})).loader_config={xpid:"UwMGWVdSGwQIU1RQAgQ="};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;oc;c++)a[c].apply(i,r);return i}function c(t,e){d[t]=f(t).concat(e)}function f(t){return d[t]||[]}function u(){return r(s)}var d={};return{on:c,emit:s,create:u,listeners:f,context:e,_events:d}}function o(){return new n}var i="nr@context",a=t("gos");e.exports=r()},{gos:"7eSDFh"}],ee:[function(t,e){e.exports=t("QJf3ax")},{}],3:[function(t){function e(t){try{i.console&&console.log(t)}catch(e){}}var n,r=t("ee"),o=t(1),i={};try{n=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(i.console=!0,-1!==n.indexOf("dev")&&(i.dev=!0),-1!==n.indexOf("nr_dev")&&(i.nrDev=!0))}catch(a){}i.nrDev&&r.on("internal-error",function(t){e(t.stack)}),i.dev&&r.on("fn-err",function(t,n,r){e(r.stack)}),i.dev&&(e("NR AGENT IN DEVELOPMENT MODE"),e("flags: "+o(i,function(t){return t}).join(", ")))},{1:25,ee:"QJf3ax"}],4:[function(t){function e(t,e,n,i,a){try{f?f-=1:r("err",[a||new UncaughtException(t,e,n)])}catch(c){try{r("ierr",[c,(new Date).getTime(),!0])}catch(u){}}return"function"==typeof s?s.apply(this,o(arguments)):!1}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function n(t){r("err",[t,(new Date).getTime()])}var r=t("handle"),o=t(6),i=t("ee"),a=t("loader"),s=window.onerror,c=!1,f=0;a.features.err=!0,t(5),window.onerror=e;try{throw new Error}catch(u){"stack"in u&&(t(1),t(2),"addEventListener"in window&&t(3),a.xhrWrappable&&t(4),c=!0)}i.on("fn-start",function(){c&&(f+=1)}),i.on("fn-err",function(t,e,r){c&&(this.thrown=!0,n(r))}),i.on("fn-end",function(){c&&!this.thrown&&f>0&&(f-=1)}),i.on("internal-error",function(t){r("ierr",[t,(new Date).getTime(),!0])})},{1:11,2:10,3:8,4:12,5:3,6:26,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],5:[function(t){if(window.addEventListener){var e=t("handle"),n=t("ee");t(1),window.addEventListener("click",function(){e("inc",["ck"])},!1),window.addEventListener("hashchange",function(){e("inc",["hc"])},!1),n.on("pushState-start",function(){e("inc",["ps"])})}},{1:9,ee:"QJf3ax",handle:"D5DuLP"}],6:[function(t){t("loader").features.ins=!0},{loader:"G9z0Bl"}],7:[function(t){function e(){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var n=t("ee"),r=t("handle"),o=t(1),i=t(2);t("loader").features.stn=!0,t(3);var a=Event;n.on("fn-start",function(t){var e=t[0];e instanceof a&&(this.bstStart=Date.now())}),n.on("fn-end",function(t,e){var n=t[0];n instanceof a&&r("bst",[n,e,this.bstStart,Date.now()])}),o.on("fn-start",function(t,e,n){this.bstStart=Date.now(),this.bstType=n}),o.on("fn-end",function(t,e){r("bstTimer",[e,this.bstStart,Date.now(),this.bstType])}),i.on("fn-start",function(){this.bstStart=Date.now()}),i.on("fn-end",function(t,e){r("bstTimer",[e,this.bstStart,Date.now(),"requestAnimationFrame"])}),n.on("pushState-start",function(){this.time=Date.now(),this.startPath=location.pathname+location.hash}),n.on("pushState-end",function(){r("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),"addEventListener"in window.performance&&(window.performance.clearResourceTimings?window.performance.addEventListener("resourcetimingbufferfull",function(){r("bstResource",[window.performance.getEntriesByType("resource")]),window.performance.clearResourceTimings()},!1):window.performance.addEventListener("webkitresourcetimingbufferfull",function(){r("bstResource",[window.performance.getEntriesByType("resource")]),window.performance.webkitClearResourceTimings()},!1)),document.addEventListener("scroll",e,!1),document.addEventListener("keypress",e,!1),document.addEventListener("click",e,!1)}},{1:11,2:10,3:9,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],8:[function(t,e){function n(t){for(var e=t;e&&!e.hasOwnProperty("addEventListener");)e=Object.getPrototypeOf(e);e&&r(e)}function r(t){a.inPlace(t,["addEventListener","removeEventListener"],"-",o)}function o(t){return t[1]}var i=t("ee").create(),a=t(1)(i),s=t("gos");e.exports=i,r(window),"getPrototypeOf"in Object?(n(document),n(XMLHttpRequest.prototype)):XMLHttpRequest.prototype.hasOwnProperty("addEventListener")&&r(XMLHttpRequest.prototype),i.on("addEventListener-start",function(t){if(t[1]){var e=t[1];if("function"==typeof e){var n=s(e,"nr@wrapped",function(){return a(e,"fn-",null,e.name||"anonymous")});this.wrapped=t[1]=n}else"function"==typeof e.handleEvent&&a.inPlace(e,["handleEvent"],"fn-")}}),i.on("removeEventListener-start",function(t){var e=this.wrapped;e&&(t[1]=e)})},{1:27,ee:"QJf3ax",gos:"7eSDFh"}],9:[function(t,e){var n=t("ee").create(),r=t(1)(n);e.exports=n,r.inPlace(window.history,["pushState","replaceState"],"-")},{1:27,ee:"QJf3ax"}],10:[function(t,e){var n=t("ee").create(),r=t(1)(n);e.exports=n,r.inPlace(window,["requestAnimationFrame","mozRequestAnimationFrame","webkitRequestAnimationFrame","msRequestAnimationFrame"],"raf-"),n.on("raf-start",function(t){t[0]=r(t[0],"fn-")})},{1:27,ee:"QJf3ax"}],11:[function(t,e){function n(t,e,n){t[0]=i(t[0],"fn-",null,n)}function r(t,e,n){this.method=n,this.timerDuration="number"==typeof t[1]?t[1]:0,t[0]=i(t[0],"fn-",this,n)}var o=t("ee").create(),i=t(1)(o);e.exports=o,i.inPlace(window,["setTimeout","setImmediate"],"setTimer-"),i.inPlace(window,["setInterval"],"setInterval-"),i.inPlace(window,["clearTimeout","clearImmediate"],"clearTimeout-"),o.on("setInterval-start",n),o.on("setTimer-start",r)},{1:27,ee:"QJf3ax"}],12:[function(t,e){function n(){f.inPlace(this,l,"fn-",o)}function r(t,e){f.inPlace(e,["onreadystatechange"],"fn-",o)}function o(t,e){return e}function i(t,e){for(var n in t)e[n]=t[n];return e}var a=t("ee").create(),s=t(1),c=t(2),f=c(a),u=c(s),d=window.XMLHttpRequest,l=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"];e.exports=a,window.XMLHttpRequest=function(t){var e=new d(t);try{a.emit("new-xhr",[e],e),e.hasOwnProperty("addEventListener")&&u.inPlace(e,["addEventListener","removeEventListener"],"-",o),e.addEventListener("readystatechange",n,!1)}catch(r){try{a.emit("internal-error",[r])}catch(i){}}return e},i(d,XMLHttpRequest),XMLHttpRequest.prototype=d.prototype,f.inPlace(XMLHttpRequest.prototype,["open","send"],"-xhr-",o),a.on("send-xhr-start",r),a.on("open-xhr-start",r)},{1:8,2:27,ee:"QJf3ax"}],13:[function(t){function e(t){var e=this.params,r=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;u>o;o++)t.removeEventListener(f[o],this.listener,!1);if(!e.aborted){if(r.duration=(new Date).getTime()-this.startTime,4===t.readyState){e.status=t.status;var i=this.lastSize||n(t);if(i&&(r.rxSize=i),this.sameOrigin){var s=t.getResponseHeader("X-NewRelic-App-Data");s&&(e.cat=s.split(", ").pop())}}else e.status=0;r.cbTime=this.cbTime,c.emit("xhr-done",[t],t),a("xhr",[e,r,this.startTime])}}}function n(t){var e=t.responseType,n="arraybuffer"===e||"blob"===e||"json"===e?t.response:t.responseText;return r(n)}function r(t){if("string"==typeof t&&t.length)return t.length;if("object"!=typeof t)return void 0;if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if("undefined"!=typeof FormData&&t instanceof FormData)return void 0;try{return JSON.stringify(t).length}catch(e){return void 0}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.sameOrigin=n.sameOrigin}var i=t("loader");if(i.xhrWrappable){var a=t("handle"),s=t(2),c=t("ee"),f=["load","error","abort","timeout"],u=f.length,d=t(1),l=t(3),p=window.XMLHttpRequest;i.features.xhr=!0,t(5),t(4),c.on("new-xhr",function(t){var n=this;n.totalCbs=0,n.called=0,n.cbTime=0,n.end=e,n.ended=!1,n.xhrGuids={},n.lastSize=0,l&&(l>34||10>l)||window.opera||t.addEventListener("progress",function(t){n.lastSize=t.loaded},!1)}),c.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),c.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid)}),c.on("send-xhr-start",function(t,e){var n=this.metrics,o=t[0],i=this;if(n&&o){var a=r(o);a&&(n.txSize=a)}this.startTime=(new Date).getTime(),this.listener=function(t){try{"abort"===t.type&&(i.params.aborted=!0),("load"!==t.type||i.called===i.totalCbs&&(i.onloadCalled||"function"!=typeof e.onload))&&i.end(e)}catch(n){try{c.emit("internal-error",[n])}catch(r){}}};for(var s=0;u>s;s++)e.addEventListener(f[s],this.listener,!1)}),c.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),c.on("xhr-load-added",function(t,e){var n=""+d(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),c.on("xhr-load-removed",function(t,e){var n=""+d(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),c.on("addEventListener-end",function(t,e){e instanceof p&&"load"===t[0]&&c.emit("xhr-load-added",[t[1],t[2]],e)}),c.on("removeEventListener-end",function(t,e){e instanceof p&&"load"===t[0]&&c.emit("xhr-load-removed",[t[1],t[2]],e)}),c.on("fn-start",function(t,e,n){e instanceof p&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=(new Date).getTime()))}),c.on("fn-end",function(t,e){this.xhrCbStart&&c.emit("xhr-cb-time",[(new Date).getTime()-this.xhrCbStart,this.onload,e],e)})}},{1:"XL7HBI",2:14,3:16,4:12,5:8,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],14:[function(t,e){e.exports=function(t){var e=document.createElement("a"),n=window.location,r={};e.href=t,r.port=e.port;var o=e.href.split("://");!r.port&&o[1]&&(r.port=o[1].split("/")[0].split("@").pop().split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]?"443":"80"),r.hostname=e.hostname||n.hostname,r.pathname=e.pathname,r.protocol=o[0],"/"!==r.pathname.charAt(0)&&(r.pathname="/"+r.pathname);var i=!e.protocol||":"===e.protocol||e.protocol===n.protocol,a=e.hostname===document.domain&&e.port===n.port;return r.sameOrigin=i&&(!e.hostname||a),r}},{}],15:[function(t,e){function n(t){return function(){r(t,[(new Date).getTime()].concat(i(arguments)))}}var r=t("handle"),o=t(1),i=t(2);"undefined"==typeof window.newrelic&&(newrelic=window.NREUM);var a=["setPageViewName","addPageAction","setCustomAttribute","finished","addToTrace","inlineHit","noticeError"];o(a,function(t,e){window.NREUM[e]=n("api-"+e)}),e.exports=window.NREUM},{1:25,2:26,handle:"D5DuLP"}],16:[function(t,e){var n=0,r=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);r&&(n=+r[1]),e.exports=n},{}],gos:[function(t,e){e.exports=t("7eSDFh")},{}],"7eSDFh":[function(t,e){function n(t,e,n){if(r.call(t,e))return t[e];var o=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:o,writable:!0,enumerable:!1}),o}catch(i){}return t[e]=o,o}var r=Object.prototype.hasOwnProperty;e.exports=n},{}],D5DuLP:[function(t,e){function n(t,e,n){return r.listeners(t).length?r.emit(t,e,n):void(r.q&&(r.q[t]||(r.q[t]=[]),r.q[t].push(e)))}var r=t("ee").create();e.exports=n,n.ee=r,r.q={}},{ee:"QJf3ax"}],handle:[function(t,e){e.exports=t("D5DuLP")},{}],XL7HBI:[function(t,e){function n(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:i(t,o,function(){return r++})}var r=1,o="nr@id",i=t("gos");e.exports=n},{gos:"7eSDFh"}],id:[function(t,e){e.exports=t("XL7HBI")},{}],G9z0Bl:[function(t,e){function n(){if(!h++){var t=p.info=NREUM.info,e=f.getElementsByTagName("script")[0];if(t&&t.licenseKey&&t.applicationID&&e){s(d,function(e,n){t[e]||(t[e]=n)});var n="https"===u.split(":")[0]||t.sslForHttp;p.proto=n?"https://":"http://",a("mark",["onload",i()]);var r=f.createElement("script");r.src=p.proto+t.agent,e.parentNode.insertBefore(r,e)}}}function r(){"complete"===f.readyState&&o()}function o(){a("mark",["domContent",i()])}function i(){return(new Date).getTime()}var a=t("handle"),s=t(1),c=window,f=c.document;t(2);var u=(""+location).split("?")[0],d={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-852.min.js"},l=window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&!/CriOS/.test(navigator.userAgent),p=e.exports={offset:i(),origin:u,features:{},xhrWrappable:l};f.addEventListener?(f.addEventListener("DOMContentLoaded",o,!1),c.addEventListener("load",n,!1)):(f.attachEvent("onreadystatechange",r),c.attachEvent("onload",n)),a("mark",["firstbyte",i()]);var h=0},{1:25,2:15,handle:"D5DuLP"}],loader:[function(t,e){e.exports=t("G9z0Bl")},{}],25:[function(t,e){function n(t,e){var n=[],o="",i=0;for(o in t)r.call(t,o)&&(n=e(o,t[o]),i+=1);return n}var r=Object.prototype.hasOwnProperty;e.exports=n},{}],26:[function(t,e){function n(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(0>o?0:o);++r
$BCRX share structure
## source: otcmarkets.com
Market Value: $511,157,991 a/o Jan 29, 2016
Shares Outstanding: 73,336,871 a/o Oct 31, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$BCRX extra dd links
Company name: BioCryst Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=BCRX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=BCRX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=BCRX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/news - http://finance.yahoo.com/q/h?s=BCRX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/BCRX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=BCRX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/BCRX
DTCC (dtcc.com): http://search2.dtcc.com/?q=BioCryst+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=BioCryst+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=BioCryst+Pharmaceuticals%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/BCRX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000882796&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=BCRX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=BCRX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=BCRX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=BCRX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=BCRX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=BCRX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=BCRX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/BCRX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=BCRX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/BCRX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=BCRX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/BCRX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/BCRX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/BCRX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/BCRX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/BCRX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=BCRX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=BCRX
$BCRX DD Notes ~ http://www.ddnotesmaker.com/BCRX
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.